METHYLPREDNISOLONE SODIUM SUCCIN. Key specifications include physical_form: POWDER, administration: INTRAMUSCULAR OR INTRAVENOUS, special_features: DILUENT IN SEPARATE BOTTLE CONTAINING 16 ML BACTERIOSTATIC WATER FOR INJECTION, features_provided: THINNER, primary_container_type: VIAL, protective_storage_feature: SUBJECT TO DAMAGE BY FREEZING. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System under NSN 6505-00-104-8069, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| administration | INTRAMUSCULAR OR INTRAVENOUS |
| special_features | DILUENT IN SEPARATE BOTTLE CONTAINING 16 ML BACTERIOSTATIC WATER FOR INJECTION |
| features_provided | THINNER |
| primary_container_type | VIAL |
| protective_storage_feature | SUBJECT TO DAMAGE BY FREEZING |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 1000.000 MILLIGRAMS |
| active_medicament_medicinal_strength | 1.000 GRAMS METHYLPREDNISOLONE ACTIVE INGREDIENT G |
| NSN | 6505-00-104-8069 |
| PHYSICAL FORM | POWDER |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| ADMINISTRATION | INTRAMUSCULAR OR INTRAVENOUS |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.000 GRAMS METHYLPREDNISOLONE ACTIVE INGREDIENT G |
| PRIMARY CONTAINER TYPE | VIAL |
| PROTECTIVE STORAGE FEATURE | SUBJECT TO DAMAGE BY FREEZING |
| FEATURES PROVIDED | THINNER |
| SPECIAL FEATURES | DILUENT IN SEPARATE BOTTLE CONTAINING 16 ML BACTERIOSTATIC WATER FOR INJECTION |
| PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 MILLIGRAMS |